Mountain Crest Acquisition 6
MCAHU · NASDAQ
About MCAHU
- Employees
- 0
- Headquarters
- New York City, New York
- Listed
- Apr 30, 2026
- Sector
- N/A
- Industry
- N/A
MCAHU key statistics
- Market cap
- 87.22M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 346
- Volume
- 57.56K
- Open price
- $10.26
- High today
- $10.26
- Low today
- $10.26
- 52 Week high
- $11.00
- 52 Week low
- $9.98
Mountain Crest Acquisition 6 (MCAHU) at a glance
As of Oct 29, 2026, Mountain Crest Acquisition 6 (MCAHU) shares are priced at $10.26, giving the company a market cap of 87.22M and a price-to-earnings ratio of 0.00.
Volume so far is 57.56K shares, above the average of 346 shares a day.
Over the past year Mountain Crest Acquisition 6 has ranged from $9.98 to $11.00, and now sits 27% of the way up that range.
Most active stocks
Highest trading volume today
- GTVHGolden Triangle Ventures$0.0001−50.00%
- BURUNuburu$0.3717+115.98%
- RDARRaadr$0.0002+0.00%
- WFFWF Holding$1.50+13.21%
- INLFINLIF$0.265+47.22%
- EARIEntertainment Arts Research$0.0002+0.00%
- ADTADT$9.87+33.20%
- AITXArtificial Intelligence Technology Solutions$0.0008+77.78%
- GOOGLAlphabet$283.82−12.64%
- NVDGraniteShares ETF Trust$4.09+2.00%
- INTCIntel$92.07−3.62%
- TIPSTianrong Internet Products & Services$0.0015+7.14%
Newly listed
Companies that went public in the past six weeks
- SCQCUSPACCircle Acquisition$9.98+0.10%
- LYCALycia Therapeutics$27.73+10.70%
- DAVIDAVION HEALTHCARE$2.69−18.24%
- TCXBTCGX Acquisition Corp. II$10.21−0.61%
- CTYCITY THERAPEUTICS$22.14+2.26%
- IAMIambic Therapeutics$14.28−3.38%
- AMROAmaero$5.78−1.37%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.21−0.20%
- TRXBTRex Bio$13.52−6.31%
- RTSNRetension Pharmaceuticals$11.83−9.63%
- PAXGUPine Tree Acquisition$10.02−0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.